Qatar German For Medical Devices · QSE:QGMD
Qatar German For Medical Devices — Qatari German Medical Devices — FY2019 Earnings Presentation
22 slides from Qatar German For Medical Devices's earnings presentation, Mar 31, 2020
Slide 1: Investors Relations Presentation
Investors Relations Presentation Qatari German Medical Devices March 31, 2020 www.qgmd.com
Slide 2: Disclaimer
The following presentation is made only to, and is directed only at, persons to whom such a presentation may lawfully be communicated (“relevant persons”). Any person who is not a relevant person should not act or rely on this presentation or any of its contents. This presentation contains forward-l
Slide 3: Agenda
Agenda Company Overview QGMD Production facilities & Machineries Recognition & Quality Assurance at QGMD What we do? QGMD News Sales Figures Financial Highlights Statement of Comprehensive Income
Slide 4: Company Overview
• QG Medical Devices is one of the leading manufacturers of Medical Devices in the Middle East and the only Manufacturing Company producing syringes and IV cannulas in Qatar. Headquartered in Doha, Company Qatar. • QG Medical Devices Co. was established in the year 2000, with Overview collaboration
Slide 5: QGMD Production Facilities & Machineries
QGMD Production Facilities & Machineries QG Medical Devices is equipped with state of art production facility designed by reputable innovative technology providers from Germany, Switzerland and Italy.
Slide 6: Recognitions & Quality Accreditation
Recognitions & Quality Accreditation Russian Certificate PCT for product ISO 9001:2015 registration ISO 13485:2016 ISO 13485:2016 EN ISO 13485:2016 EN ISO 13485:2016
Slide 7: Quality in Focus
Quality in Focus QG MEDICAL DEVICES > . QUALITY CONTROL Qa e Qs a3 3 QUALITY ASSURANCE . se ‘ a vv QUALITY IDENTIFY - THE REVIE Ww CONTINUOUS ow ehangoe IMPROVEMENT ke CYCLE
Slide 8: Certification and Accreditation
Certification and Accreditation Certified to ISO 13485 : 2016 On-Going to
Slide 9: World Health Organization Accreditation for Q SAFE Re-Use Prevention Syringes
World Health Organization Accreditation for Q SAFE Re-Use Prevention Syringes
Slide 10: What We Do?
What We Do? QGMD is striving to become a leading medical devices manufacturer in the healthcare industry worldwide, as well as a strong partner in the medical trading and services industry; by continuing to introduce innovative and superior medical devices which guarantee better patient care. • We s
Slide 11: Manufacturing (Q JECT, Q SAFE, Q JECT Ultra, Q FLOW, Q NEED)
Manufacturing (Q JECT, Q SAFE, Q JECT Ultra, Q FLOW, Q NEED)
Slide 12: Trading (Medical Consumables, Medical Equipment & Furniture)
Trading (Medical Consumables, Medical Equipment & Furniture)
Slide 13: QGMD News
QGMD News • QGMD was awarded by Armstrong Medical & The 37 companies as best partner achiever! • QGMD was awarded to supply various medical supply with contract value of QAR 18.6 Million (8.8 M airinspace ; 1.5 M Pall; 400K for gloves; 2.9 M for 37 companies; 200K for Trademed (underpads); 3.4 M for
Slide 14: QGMD News
QGMD News • QGMD was visited by ICIN- Scientific Bureau Iraq to finalize partnership for the IRAQI Tenders of KIMADIA and private sector • QGMD was visited by Al Duwaila Pharma to finalize partnership for the IRAQI Tenders of KIMADIA and private sector
Slide 15: QGMD News
QGMD News • QGMD was visited by MSB Medical Pakistan to sign the agreement of exclusive distribution of QG products in Pakistan • Order value closed was QAR 500,000 for the first confirmed order; forecasted for the rest of the year at QAR 3.65 Million
Slide 16: QGMD News
QGMD News • QGMD was awarded with the Long Term Agreement with WHO- PAHO (World Health Organization- Pan American Health Organization) for the supply of conventional syringes for the year 2020-2021 • 1cc with needle G22x 1 ½ = 2.4 Million pcs. • 1cc with needle G23x 1 = 5.6 Million pcs.
Slide 17: Statement of Comprehensive Income
Statement of Comprehensive Income
Slide 18: Analysis of the financial statements for the year 2019
Analysis of the financial statements for the year 2019 • During 2019 the following achieved I. General & Admin Expenses reduced by 46.98% II. Imperilment loss nil III. No Provision taken for Trade Receivables IV. No Provision taken for slow moving items for inventory V. Finance Cost reduced by 10.53
Slide 19: Ratio Analysis
Ratio Analysis Liquidity Sum of 2019 Sum of 2018 700 600 581.21 532.84 500 400 300 204.711 200 170.163 100 0.088 0.658 0.827 0 -0.042 -100 Current Cash Debt Coverage Average Collection Period Current Ratio Days in Inventory Ratio Sum of 2019 170.163 0.088 0.658 581.21 Sum of 2018 204.711 -0.042 0.82
Slide 20: Ratio Analysis
Ratio Analysis Solvency 2500000 2000000 1845304 1500000 1000000 500000 0.0157 -0.0112 0.801 0.747 0 -1.885 -2.19 -500000 -1000000 -1500000 -1585451 -2000000 Cash Debt Coverage Ratio Debt to Total Assets Ratio Free Cash Flow Times Interest earned Ratio Sum of 2019 0.0157 0.801 1845304 -1.885 Sum of 2
Slide 21: Ratio Analysis
Ratio Analysis PROFITABILITY 0.4 0.2565 0.2 0.0684 0.0948 0.0514 0 -0.0656 -0.077 -0.2 -0.4 -0.6 -0.8 -0.784 -1 -1.2 -1.125 Asset Turnover Ratio Gross Profit Rate Profit margin Ratio Return on Assets Ratio Sum of 2019 0.0514 0.0948 -0.784 -0.0656 Sum of 2018 0.0684 0.2565 -1.125 -0.077 Sum of 2019 S
Slide 22: Thank you
Thank you Qatari German Medical Devices March 31, 2020 www.qgmd.com
Qatari German Medical Devices — FY2019 Earnings Presentation on 6ix